| HOME >> BIOLOGY >> TECHNOLOGY |
VANCOUVER, Sept. 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 24 - 27 in New York.
On Monday, September 24, 2007 at 8:30am ET, Dr. William Hunter, President and Chief Executive Officer of Angiotech, will give a 25-minute presentation.
A link to the live audio webcast of Dr. Hunter's remarks will be available to all interested parties on Angiotech's website at http://www.angiotech.com/ in the Investors section. The webcast will also be archived and available for replay until October 27, 2007.
Note on Forward Looking Statements:
Statements contained in this press release that are not based on
historical fact, including without limitation statements containing the
words "believes," "may," "plans," "will," "estimate," "continue,"
"anticipates," "intends," "expects" and similar expressions, constitute
"forward-looking statements" within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and constitute "forward-looking
information" within the meaning of applicable Canadian securities laws. All
such statements are made pursuant to the "safe harbor" provisions of
applicable securities legislation. Forward-looking statements may involve,
but are not limited to, comments with respect to our objectives and
priorities for 2007 and beyond, our strategies or future actions, our
targets, expectations for our financial condition and the results of, or
outlook for, our operations, research development and product and drug
development.
'/>"/>
| SOURCE Angiotech Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |